| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| ABBOTT LABORATORIES | EXECUTIVE VICE PRESIDENT, GC | Common shares without par value | 191,899 | $26,073,317 | $135.87 | 28 Feb 2025 | Direct |
| ABBOTT LABORATORIES | EXECUTIVE VICE PRESIDENT, GC | Common shares without par value | 184,806 | $21,899,511 | $118.50 | 01 Mar 2024 | Direct |
| ABBOTT LABORATORIES | EXECUTIVE VICE PRESIDENT, GC | Option (right to buy) | 57,635 | 25 Feb 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 28 Feb 2025 | 1 | -$1,138,862 | 4 | EXECUTIVE VICE PRESIDENT, GC | 04 Mar 2025, 19:00 |
| ABT | ABBOTT LABORATORIES | 25 Feb 2025 | 2 | $0 | 4 | EXECUTIVE VICE PRESIDENT | 27 Feb 2025, 17:37 |
| ABT | ABBOTT LABORATORIES | 29 Jan 2025 | 6 | -$17,054,444 | 4 | EXECUTIVE VICE PRESIDENT | 31 Jan 2025, 19:16 |
| ABT | ABBOTT LABORATORIES | 21 Oct 2024 | 5 | -$11,025,511 | 4 | EXECUTIVE VICE PRESIDENT | 23 Oct 2024, 17:10 |
| ABT | ABBOTT LABORATORIES | 29 Feb 2024 | 2 | -$1,087,171 | 4 | EXECUTIVE VICE PRESIDENT | 04 Mar 2024, 18:39 |
| ABT | ABBOTT LABORATORIES | 21 Feb 2024 | 2 | $0 | 4 | EXECUTIVE VICE PRESIDENT | 23 Feb 2024, 17:03 |
| ABT | ABBOTT LABORATORIES | 28 Feb 2023 | 2 | -$957,190 | 4 | EXECUTIVE VICE PRESIDENT | 02 Mar 2023, 18:16 |
| ABT | ABBOTT LABORATORIES | 17 Feb 2023 | 2 | $0 | 4 | EXECUTIVE VICE PRESIDENT | 22 Feb 2023, 17:37 |
| ABT | ABBOTT LABORATORIES | 28 Feb 2022 | 2 | -$1,380,514 | 4 | EXECUTIVE VICE PRESIDENT | 02 Mar 2022, 18:29 |
| ABT | ABBOTT LABORATORIES | 18 Feb 2022 | 2 | $0 | 4 | EXECUTIVE VICE PRESIDENT | 23 Feb 2022, 18:58 |